CORC  > 中南大学
Tyrosine receptor kinase B silencing inhibits anoikis-resistance and improves anticancer efficiency of sorafenib in human renal cancer cells
Zhang, Peng; Xing, Zengshu; Li, Xuechao; Song, Yarong; Zhao, Jun; Xiao, Yajun; Xing, Yifei*
刊名INTERNATIONAL JOURNAL OF ONCOLOGY
2016
卷号48期号:4页码:1417-1425
关键词renal cell carcinoma anoikis invasion tyrosine receptor kinase B sorafenib Akt ERK
ISSN号1019-6439
DOI10.3892/ijo.2016.3356
URL标识查看原文
WOS记录号WOS:000372567100012
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3343820
专题中南大学
作者单位1.[Zhang, Peng
2.Xiao, Yajun
3.Song, Yarong
4.Zhao, Jun
5.Li, Xuechao
6.Xing, Yifei] Huazhong Univ Sci & Technol, Union Hosp, Dept Urol, Tongji Med Coll, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.
推荐引用方式
GB/T 7714
Zhang, Peng,Xing, Zengshu,Li, Xuechao,et al. Tyrosine receptor kinase B silencing inhibits anoikis-resistance and improves anticancer efficiency of sorafenib in human renal cancer cells[J]. INTERNATIONAL JOURNAL OF ONCOLOGY,2016,48(4):1417-1425.
APA Zhang, Peng.,Xing, Zengshu.,Li, Xuechao.,Song, Yarong.,Zhao, Jun.,...&Xing, Yifei*.(2016).Tyrosine receptor kinase B silencing inhibits anoikis-resistance and improves anticancer efficiency of sorafenib in human renal cancer cells.INTERNATIONAL JOURNAL OF ONCOLOGY,48(4),1417-1425.
MLA Zhang, Peng,et al."Tyrosine receptor kinase B silencing inhibits anoikis-resistance and improves anticancer efficiency of sorafenib in human renal cancer cells".INTERNATIONAL JOURNAL OF ONCOLOGY 48.4(2016):1417-1425.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace